MetaCap

OPKO Health (OPK) vs First Tracks Biotherapeutics (TRAX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

First Tracks Biotherapeutics is the larger company by market cap ($1.09 billion vs $1.04 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OPK+19.83%TRAX+30.17%
+99%+30%-38%
Apr 6, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OPK versus TRAX key metrics
MetricOPKTRAX
Share price$1.39$30.59
Market cap$1.04B$1.09B
1-day change-4.79%-2.55%
YTD return+10.32%—
1-year return-9.74%—
5-year return-62.63%—
EPS (TTM)$-0.09$-4.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.75$49.91
52-week low$0.98$14.72
Distance from 52-week high-20.57%-38.71%
Average volume3.35M788.93K
Shares outstanding746.33M35.73M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

OPK vs TRAX FAQ

Which is bigger, OPKO Health or First Tracks Biotherapeutics?

First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.09B compared with $1.04B for OPKO Health (OPK).

Are OPKO Health and First Tracks Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons